CYCC – cyclacel pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock [Yahoo! Finance]
Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock
Form DEF 14C Cyclacel Pharmaceuticals For: Apr 03
Form 10-K Cyclacel Pharmaceuticals For: Dec 31
Form 8-K Cyclacel Pharmaceuticals For: Mar 31
Form NT 10-K Cyclacel Pharmaceuticals For: Dec 31
Form D Cyclacel Pharmaceuticals
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.